pirfenidone has been researched along with Intestinal Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bollmann, G; Cosín-Roger, J; Fagagnini, S; Hausmann, M; Hünerwadel, A; Lang, S; Lutz, C; Mamie, C; Meier, R; Rogler, G; Tchouboukov, A; Weber, A; Weber, FE | 1 |
1 other study(ies) available for pirfenidone and Intestinal Diseases
Article | Year |
---|---|
Decreased Fibrogenesis After Treatment with Pirfenidone in a Newly Developed Mouse Model of Intestinal Fibrosis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Cell Proliferation; Collagen; Disease Models, Animal; Female; Fibrosis; Immunoenzyme Techniques; Intestinal Diseases; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pyridones; Transforming Growth Factor beta | 2016 |